Yes, that is what the CFO had said. That is why we are set to have a strong 4th quarter. Next Thursday should be very interesting as to how much of a hint (if any) Levin gives about the December 11th conference. My guess is he won't give much. Compared to a clam he has been an oyster. I will say though the last several weeks there have been several drugs in late stage developments which have produced positive data. The company appears to be heading down the right path.
Hey cd, I've noticed the positive results in the studies. You mention the CFO was the person who talked about all the approvals. You know I'm not a big fan of what he verbalizes. I thought something like 30 or 40 in the second half were looking for approval. We're a far cry from that, (if that is correct) unless the company doesn't think some approvals not important enough to be published.